Loading transcript...
Click for full transcript
Chapters & Sections (124)
▼
0:00
Cartel Involvement in Pharmaceutical Industry
2:55
CEO Discusses Company and Modern Legalization
5:29
Introduction to the Cat Ratom Plant
7:01
Ratam's Dual Effects and Preparation Methods
8:41
History of Kratom Consumption in the US
10:00
History of Supplement Industry and Product Development
12:42
Regulatory Loopholes in the Supplement Industry
14:34
Supplement Industry Lack of Quality Control
16:48
Risks and Regulation of Synthetic Cannabinoids
18:45
Regulatory Scheduling of Highly Potent Opioids
19:59
Salmonella Outbreak Linked to Kratom Consumption
22:29
Regulatory Challenges in Psychedelic Plant-Based Business
24:33
Founding Story of a Supplement Company
26:08
Risks of Unregulated Substance Legalization
27:22
Regulatory Challenges in Conducting Safety Studies
28:40
Conducting FDA-Approved Clinical Trials for New Drugs
30:13
Challenges of Validating New Pharmaceutical Substances
32:06
Regulation of Dietary Supplements in Industry
33:14
Combining AI, Quantum, and Blockchain in Supplement Industry
34:34
Unlocking Hidden Connections in Scientific Research
36:07
Monopolies and Lack of Product Regulation
38:10
Deception in Organic and Grass-Fed Labeling Practices
39:37
Marketing Influence on Consumer Choices
40:50
The Risks of Non-Degradable Chemicals in Everyday Life
42:24
Consequences of Unintended Consequences in Society
43:57
Cycles of History and Industry Evolution
45:28
Opioid Replacement Industry Misrepresentation
46:39
Opioid Receptors and Agonist Mechanisms Explained
48:32
Confusion Around Potent Opioid Metabolites Explained
50:58
Metragene's Potency and Safety Testing Protocols
52:52
Searching for Manufacturing Capacity for Psychedelic Research
54:11
Isolation and Potency of 7 Hydroxy Metroine
56:00
Opioid Analgesic Effects and Addiction Potential
58:43
Comparing Potency of 7 Hydroxy to Morphine
59:54
Bioavailability of Medicinal Products in the Body
1:01:27
Phytochemical Interactions in Full Spectrum Substances
1:03:23
Risks of 7 Hydroxy Cannabinoid Overdose
1:05:36
Risks of High-Dose Synthetic Opioid Use
1:07:03
Addiction to Highly Potent Synthetic Opioid
1:09:52
Breaking into Mainstream Cannabis Industry
1:11:28
Rethinking the Approach to Pharmaceutical Development
1:12:46
Navigating the Challenges of High-Potency Medications
1:14:02
Addiction and Regulation of Potent Opioid Alternatives
1:15:53
FDA Regulation of Emerging Psychedelic Substances
1:17:05
Transparency in Pharmaceutical Manufacturing Process
1:18:29
Responding to Wrongful Death Lawsuit Allegations
1:20:15
Ratam Toxicity and Heart Attack Investigation
1:22:51
Unexpected Interactions with Bioavailability and Supplements
1:24:42
Contraindications and Product Safety Measures
1:27:02
Supply Chain Transparency and Product Safety Measures
1:28:48
Blockchain Technology in Food Supply Chain
1:30:06
Blockchain Validation and Data Transparency
1:31:46
Blockchain Validation in Supply Chain Management
1:33:13
Blockchain Anonymity and Time Stamping Validation
1:34:35
Blockchain-Based Anti-Illicit Fishing System
1:36:29
Blockchain Validation in the Age of AI
1:38:16
Blockchain Security and Transparency in Business
1:40:24
Rapid Advancements in AI Technology and Implications
1:41:42
Simulation Theory and Existential Questions
1:44:24
Philosophical Implications of Simulation Hypothesis
1:46:10
Regulating Highly Potent Opioids in the Market
1:48:36
Addictive Properties of Potent Opioids
1:50:45
Opioid Crisis and New Synthetic Opioid Market
1:52:30
Math Behind Addiction Prevention Strategies
1:55:09
Regulating Synthetic Derivatives in the US
1:57:32
Consequences of Unregulated Pharmaceutical Industry
1:59:38
The Dangers of Unregulated Prescription Painkillers
2:01:30
Fentanyl Overdose and Addiction to Cocaine
2:03:46
Regulating Highly Potent Synthetic Opioids
2:04:58
Addressing Opioid Addiction in Pharmaceutical Industry
2:06:13
Opioid Crisis and Schedule One Narcotics
2:08:15
Challenges in Regulating Highly Potent Synthetic Opioids
2:10:02
Experiencing Cartel Surveillance in Washington D.C.
2:12:18
Unsettling Encounters with Unusual Knowledge of Personal Plans
2:14:30
Surveillance and Security Threats in Modern Life
2:16:33
International Narcotics Trafficking and Money Laundering
2:18:09
Cartel Involvement in Illicit Drug Trade
2:19:23
Cartel and CCP's Role in Opioid Trafficking
2:21:10
Protecting Business from Industrial Espionage
2:23:07
Experiencing Harassment and Surveillance
2:24:36
CIA Cartel Money Laundering Operations Exposed
2:25:50
Government Agencies and Organized Crime Ties
2:27:52
Government Corruption and Cartel Involvement Exposed
2:29:50
Illicit Fentanyl Trade and Capitalist Vulnerabilities
2:34:38
Regulation of Potent Narcotics and Harm Reduction
2:36:22
Regulating Potent Cannabinoid Extracts and Derivatives
2:37:40
Regulating the Sale of Potent Opioid Alternatives
2:40:07
NSF Certification Process for Supplement Manufacturers
2:43:09
Reversing Alzheimer's and Dementia with Peptide Research
2:44:24
Pharmaceutical Company Acquisition and Funding Negotiations
2:47:28
Regulating Potent New Opioid Derivatives Safely
2h 58m⏭ 2
2h 49m⏭ 3
3h 3m⏭ 2
3h 18m⏭ 1
3h 18m⏭ 2
3h 3m⏭ 2
2h 50m⏭ 2
3h 11m⏭ 1
3h 3m⏭ 2
2h 52m⏭ 2
2h 54m⏭ 1
⏭ 3
48m⏭ 1
1h 20m
1h 40m⏭ 3
1h 22m
1h 50m⏭ 3
1h 0m⏭ 1
31m⏭ 1
4h 6m⏭ 2
1h 16m⏭ 4
2h 15m⏭ 2
1h 1m
1h 28m⏭ 2